UK News Archive

The UK News Archive contains resources intended for journalists only.

2021

April

Media Release / Apr 21, 2021

NICE recommends Novartis’ Kesimpta®▼ (ofatumumab) for patients living with relapsing remitting multiple sclerosis (RRMS)

Read More
Media Release / Apr 21, 2021

Industry leaders launch HealthHub 21 to scale-up digital solutions for faster & more accessible care

Read More
Media Release / Apr 07, 2021

Novartis receives European and UK licence for Kesimpta® ▼ (ofatumumab), the first self-administered B-cell therapy for patients with relapsing forms of MS

Read More
Media Release / Apr 06, 2021

Novartis UK updated statement on Estradot Stock

Read More

March

Media Release / Mar 31, 2021

Novartis launches ‘See What’s Next’, a disease awareness campaign to support people with wet AMD to remain independent for longer

Read More
Media Release / Mar 26, 2021

Novartis UK and Cievert announce digital innovation partnership to support the NHS in its recovery

Read More
Media Release / Mar 08, 2021

Novartis UK updated statement on Estradot stock

Read More
Media Release / Mar 08, 2021

Landmark agreement enables families in England to have access to innovative one-time gene therapy on the NHS

Read More

February

Media Release / Feb 26, 2021

Novartis’ Kisqali® (ribociclib) receives NICE recommendation for routine funding as second-line treatment of hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer

Read More
Media Release / Feb 17, 2021

Maintain COVID-19 collaborations to secure UK’s life sciences lead, recommends new report

Read More

Related Links